Greg Chow

Greg Chow currently serves as the Chief Financial and Business Officer at NodThera since August 2024. Prior to this role, Chow held the position of Chief Financial Officer at Freenome from January to August 2024 and at Frontier Medicines from March 2021 to January 2024. Chow was also the Executive Vice President and Chief Financial Officer at Aptose Biosciences, Inc. from November 2013 to March 2021. Earlier in the career, Chow worked as Managing Director and Director of Private Placements at Wedbush Securities from April 2012 to November 2013, where the focus was on venture capital and private equity relationships. Greg Chow earned a BA in Business Economics with a concentration in Accounting from UC Santa Barbara and an MBA in Finance from The Wharton School.